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fluids, either by diuretics or by ultrafiltration, rather than 
infusing them. Still, nephrologists like to think of them-
selves as experts in fluid, electrolyte, and acid-base bal-
ance. This is directly linked to IV fluids as IV fluid therapy 
implies infusing fluid, electrolytes, and buffers directly into 
the extracellular fluid volume. IV fluids can be used to cor-
rect electrolyte or acid-base disorders, while—equally so—
their inadequate use can cause these disorders (Tables  1, 
2). Nephrologists are often asked for advice on IV fluids 
in consultative services, for example in the intensive care, 
surgical or medical wards. Regardless of the context, the 
proper prescription of IV fluids requires understanding of 
physiology. Or, stated more eloquently, “their appropriate 
use requires reverence for the fine balance that constitutes 
human homeostasis [1].” A useful approach is to consider 
IV fluids as drugs, including specific pharmacokinetic and 
pharmacodynamics properties (as recently reviewed by us 
[2]). In addition, to understand the current selection of the 
types of IV fluids, it is useful to briefly review the history 
of IV fluids in medicine. One of the pioneers in applying 
IV fluids was Dr. Thomas Latta who, during the cholera 
epidemic in 1832, instead of infusing fluid into the colon, 
decided to “throw it immediately in the circulation” [3]. He 
used a fluid consisting of “soda and two scruples of subcar-
bonate of soda in six pints of water”, which was remark-
ably effective, but also quickly forgotten [4]. Between 
1882 and 1885 the British physiologist Dr. Sydney Ringer 
conducted his so-called “extravital investigations” and 
developed a fluid which enabled a frog’s heart to continue 
beating outside the body by using a solution comparable 
to blood plasma [5, 6]. In 1932 the American pediatrician 
Dr. Alexis Hartmann modified Ringer’s solution by adding 
the buffer lactate [7, 8]. The IV fluid lactated Ringer’s or 
Hartmann’s solution still reminds us today of these achieve-
ments and may be considered the first balanced solutions 
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(Table 3). Around 1900 the Dutch physiologist Dr. Hartog 
Jacob Hamburger developed “physiological” or “normal” 
saline, i.e. 0.9% sodium chloride [9, 10]. In retrospect, the 
adjectives “physiological” and “normal” may be considered 
misnomers, because especially the chloride concentration 
in 0.9% NaCl is supraphysiological (154 vs. 100  mmol/l, 
Table 3) [11]. The fluids developed by Latta, Ringer, Hart-
mann, and Hamburger all qualify as crystalloids, water 
with electrolytes forming a solution. Crystalloids should be 
distinguished from colloids, in which—chemically speak-
ing—insoluble particles are suspended, but not in solution. 
A naturally occurring colloid is albumin, which was first 
used to treat trauma casualties, including burn patients after 
the Pearl Harbor attack [12]. Today, albumin is occasion-
ally used in severe hypovolemic shock, and in patients with 
liver failure [13]. Other colloids include dextrans, hydroxy-
ethyl starches, and gelatins. Colloids will not be reviewed 
in detail here, because they are being used less frequently 
after several signals that they may cause harm (increased 
mortality [14] and acute kidney injury (AKI) [15]), espe-
cially after retraction of the articles by Dr. Joachim Boldt 
[16]. Instead, this review will focus on the evolving field of 
crystalloid IV fluids.
Indications for intravenous fluids
IV fluids are so ubiquitous in clinical medicine that one 
would almost forget considering its indications (Table  1). 
An important classification is the distinction between 
replacement and maintenance IV fluids. Patients requir-
ing replacement IV fluids have a degree of volume deple-
tion that may be due to hemorrhagic or non-hemorrhagic 
causes. For both categories, the rapid infusion of isotonic 
saline is indicated for resuscitation (e.g., 500 ml in 10 min, 
repeated as needed). Isotonic IV fluids expand the intravas-
cular compartment more effectively than hypotonic IV flu-
ids. No studies are available to address whether balanced 
crystalloids offer advantages in this setting [17]. Colloids 
are not recommended because of their adverse effects (dis-
cussed above) and also because they may be less effective 
[18]. In less severe volume depletion, the goal of replace-
ment therapy is to correct existing abnormalities in fluid, 
electrolyte, or acid-base balance. Furthermore, IV fluids 
may be used in patients with pre-renal azotemia in the con-
text of AKI or acute on chronic renal insufficiency. The 
fractional excretion of urea rather than sodium may be use-
ful to select patients eligible for a trial of fluid repletion 
[19]. Maintenance IV fluids are usually given when the 
patient cannot drink for a prolonged period of time. Owing 
to immobility, hospitalized patients often require less than 
a liter of water per day. However, this rough estimate can 
change dramatically in circumstances with increased loss 
due to fever, sweating, burns, tachypnea, gastro-intestinal 
losses, drains, or polyuria. Conversely, non-osmotic stim-
uli may be present for the release of vasopressin (the anti-
diuretic hormone), resulting in renal water retention [20]. 
Table 1  Indications for intravenous fluids
Replace extracellular fluid volume losses
Maintain fluid and electrolyte balance
Correct existing electrolyte or acid-base disorders
Provide a source of glucose
Table 2  Complications of intravenous fluids
Typical type of IV fluid Complication
Normal saline Hyperchloremic metabolic 
acidosis, worsening hyper-
tension
Hypotonic IV fluids Hyponatremia
Hypertonic or isotonic IV fluids Hypernatremia
Usually isotonic IV fluids Fluid overload
Table 3  Composition of 
commonly used intravenous 
fluids
All in mmol/l, except for osmolality in mOsm/kg. N/A not available
a Buffers consist of bicarbonate (plasma, NaHCO3), lactate (lactated Ringer’s), acetate (27 mmol/l in Plas-
maLyte, 24 mmol/l in Sterofundin), gluconate (23 mmol/l in PlasmaLyte), and maleate (5 mmol/l in Stero-
fundin)
Osmolality Tonicity Na+ Cl− K+ Mg2+ Ca2+ Buffera
Plasma 288 Reference 140 103 4.5 1.25 2.5 24
0.9% NaCl 308 Isotonic 154 154 0 0 0 0
Lactated Ringer’s 279 Hypotonic 130 111 4.0 0 2.7 29
PlasmaLyte N/A Isotonic 140 98 5.0 1.5 0 50
Sterofundin 309 Isotonic 140 127 4.0 1.0 2.5 29
5% Glucose 278 Hypotonic 0 0 0 0 0 0
1.4% NaHCO3 333 Hypertonic 167 0 0 0 0 167
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Changes in body weight and the serum sodium concentra-
tion (as measure of water balance) are useful parameters to 
assess water balance and, accordingly, plan initial IV fluid 
therapy. Other parameters should also guide the selection 
of IV fluid therapy, including blood pressure, acid-base sta-
tus, kidney function, and the presence of diabetes. In gen-
eral, isotonic IV fluids are recommended for maintenance 
[20], but specific settings may require tailored therapy. 
Recommended average rates of infusion are 100–120 ml/h, 
but should be decreased (25  ml/h in oligoanuric states, 
40–60 ml/h in edematous states) or increased (>120 ml/h 
with urinary concentrating defect) depending on the clini-
cal context [20]. The tendency towards isotonic mainte-
nance IV fluids may be related to previous cases of acute 
hyponatremia, for example due to the combination of post-
operative vasopressin release and the use of hypotonic IV 
fluids [21]. In addition, because IV fluid therapy can cause 
fluid overload, and a positive fluid balance in the ICU is 
associated with higher mortality [22], the need for giving 
maintenance fluids should always be critically reviewed 
[23]. Although IV fluids often contain glucose, it offers a 
poor source of long-term nutrition, which should usually 
come from enteral tube feeding. Alternatively, in patients 
with compromised gut function, total parental nutrition 
may be indicated. These considerations raise the question if 
glucose should be part of maintenance IV fluids. This prac-
tice differs per country and no large studies are available 
comparing isotonic maintenance fluids with or without dex-
trose. One randomized trial in the peri-operative setting did 
show that 72% of patients receiving IV fluids containing 
dextrose developed transient hyperglycemia, whereas those 
without dextrose remained normoglycemic [24]. Because 
hyperglycemia is associated with worse outcomes after 
acute neurological injury, dextrose may need to be avoided 
especially in this setting [25, 26]. When hypoglycemia is 
a potential risk (e.g., during surgery in children) dextrose 
levels can be safely reduced from 5 to 1% (Table 4) [27].
Etiology of saline‑induced acidosis
Normal saline has long been the dominant type of IV fluid 
both for replacement and maintenance. A unique side-effect 
of normal saline is hyperchloremic metabolic acidosis. A 
straightforward question without a clear answer is why 
“normal” saline causes hyperchloremic acidosis. Normal 
saline differs from other IV fluids in two regards: it does 
not contain a buffer and it has a higher chloride concen-
tration. Indeed, both the change in serum chloride and the 
volume of infused 0.9% NaCl correlated with the degree 
of acidosis in one study [28]. One possibility, therefore, is 
that expansion of the extracellular fluid with a buffer-free 
fluid dilutes serum bicarbonate and therefore causes aci-
dosis. This phenomenon of “dilution acidosis”, however, 
is not linear because experimental data showed that a 28% 
expansion of the extracellular fluid volume reduced serum 
bicarbonate by only 10% [29]. The degree of acidosis is 
likely attenuated by mobilization of intracellular bicar-
bonate (e.g., from bone) and binding of hydrogen ions by 
albumin and hemoglobin. Subsequent clinical cases, how-
ever, did find the degree of acidosis to be predictable by 
the amount of normal saline [30]. Both Gattioni et al. and 
Doberer et al. performed in vitro experiments to investigate 
the basis of dilution acidosis [31, 32]. They concluded that, 
for dilution acidosis to occur, the infused volume should 
largely exceed urine output, and an open CO2/HCO3− 
buffer system should exist, where the buffer base (HCO3−) 
but not the buffer acid (CO2) is diluted [31]. In a com-
mentary accompanying both studies, Davenport offered 
yet another explanation focusing on the observation that 
hyperchloremic acidosis usually occurs in a phase of clini-
cal improvement [33]. He suggested that improved organ 
perfusion results in a “wash out” of lactate, organic acids, 
and other intermediary metabolites. This, however, should 
increase the serum anion gap, which is usually normal in 
hyperchloremic acidosis. Dilution acidosis is also unlikely 
to be a renal phenomenon (i.e., due to reduced bicarbonate 
reabsorption or reduced proton excretion), because it has 
also been reported in patients with end-stage renal disease 
receiving normal saline [34], and the kidney responds with 
an appropriate increase in NH4+ excretion [35].
Comparing solutions
The development of hyperchloremic metabolic acidosis 
during IV fluid therapy has led to the search for alterna-
tive options. Continuous hemorrhage experiments in dogs 
Table 4  Answered and 
unanswered questions Sufficient evidence Unanswered questions
Crystalloids have fewer side-effects than colloids Are balanced crystalloids better than normal saline?
Normal saline can cause hyperchloremic acidosis and 
impair coagulation
Which balanced crystalloid is preferable?
Isotonic rather than hypotonic maintenance IV fluids 
are preferable in pediatrics
Should maintenance IV fluids contain glucose?
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showed that resuscitation with lactated Ringer’s kept 
blood pH stable at 7.40, while normal saline reduced it 
slightly to 7.36 [36]. In humans, a 2-h peri-operative infu-
sion of 30 ml/kg/h normal saline but not lactated Ringer’s 
increased serum chloride (104 to 115 mmol/l) and reduced 
pH (7.40  to  7.28) [37]. The authors considered this phe-
nomenon benign unless confused with hypoperfusion or 
when superimposed with respiratory acidosis by analgetics 
in the post-operative phase. In a double-blind randomized 
trial, patients who received normal saline while undergo-
ing aortic reconstructive surgery required more bicarbonate 
supplementation and more blood products [38]. However, 
no differences in the duration of mechanical ventilation, 
intensive care or hospital stay, and incidence of complica-
tions were noted [38]. Subsequent studies confirmed the 
differential effects on coagulation of IV fluids, ascribing 
this both to a dilutional coagulopathy by normal saline [39] 
and the development of hypercoagulability with lactated 
Ringer’s [40]. Together, these head-to-head comparisons 
clearly show that normal saline causes hyperchloremic 
metabolic acidosis and impairs coagulation. Because these 
fluids were given for relatively short periods of time (peri-
operatively or during resuscitation after trauma), long-
term outcomes were more difficult to evaluate. Still, these 
studies likely spurred the development of newer balanced 
crystalloid solutions, including PlasmaLyte and Sterofun-
din (Table 3). For PlasmaLyte and Sterofundin other buff-
ers than lactate are used (acetate and maleate) and these 
solutions are isotonic compared to the mildly hypotonic 
lactated Ringer’s [41]. Since their introduction, several 
studies have been performed with these newer balanced 
crystalloids. In healthy volunteers, 2 l of normal saline but 
not PlasmaLyte increased serum chloride and reduced renal 
artery flow velocity and renal cortical tissue perfusion (as 
measured by magnetic resonance imaging) [42]. This effect 
may be a direct consequence of hyperchloremia, which has 
been shown to produce renal vasoconstriction and a fall in 
glomerular filtration rate [43]. This effect on renal blood 
flow may have contributed to a greater expansion of the 
extracellular fluid volume with normal saline. Indeed, the 
excretion of both water and sodium are slower after 2 l of 
normal saline than after a balanced solution [11]. Because 
the hypertensive effect of sodium also depends on chlo-
ride, normal saline may increase blood pressure, especially 
in hypertensive patients [44]. Although observational, a 
study on postoperative IV fluids also favored PlasmaLyte 
over normal saline [45]. The use of normal saline after 
open abdominal surgery was associated with higher mortal-
ity, and more infections, blood transfusions, renal replace-
ment therapy (RRT), electrolyte disorders, and acidosis 
[45]. One of the first large prospective studies was an open-
label, sequential period pilot study comparing a so-called 
“chloride-liberal” IV fluid regimen (normal saline, gelatin, 
albumin) to a “chloride-restrictive” regimen (Hartmann’s 
solution, PlasmaLyte, chloride-poor albumin) [46]. The 
chloride-restrictive regimen nearly halved the risk of AKI 
and RRT. In a 6-month extension of this study these dif-
ferences in renal outcomes remained [47]. In contrast, the 
more recent and controlled SPLIT trial (double-blind and 
double-crossover) compared normal saline with Plasma-
Lyte in 2278 ICU-patients and found no differences in the 
incidences of AKI or RRT [48]. Of note, this study did not 
report serum chloride concentrations and a relatively small 
volume (median of 2 l) was infused in patients with moder-
ate severity of disease [49]. Finally, and quite surprisingly, 
no sample size calculations were performed [48].
Intravenous fluids in specific settings
Kidney transplantation
If high-chloride IV fluids indeed impair renal blood flow 
or even kidney function, the type of IV fluid during kid-
ney transplantation may be particularly relevant. O’Malley 
et  al. addressed this issue in a double-blind randomized 
trial comparing lactated Ringer’s to normal saline (primary 
outcome was serum creatinine at day 3) [50]. The study was 
terminated prematurely because significantly more patients 
in the normal saline group developed hyperchloremic aci-
dosis and hyperkalemia (serum potassium >6  mmol/l) 
[50]. Of interest, urine output and graft function were also 
significantly worse in the normal saline group even a few 
days after transplantation. Recently, a Cochrane analysis 
was performed on this topic including the six studies that 
have been performed to date (477 patients, 70% live donor) 
[51]. In this analysis, the use of normal saline was associ-
ated with a higher risk of hyperchloremic acidosis, but not 
hyperkalemia or delayed graft function. No intervention 
studies in other solid organ transplantations are available. 
However, an observational study in 158 liver transplanta-
tions identified the use of >3.2  l of chloride-liberal fluids 
and a higher pre-operative model for end-stage liver disease 
(MELD) score as independent predictors for postoperative 
AKI (occurring in a third of the patients) [52].
Pediatrics
Until recently IV fluids in pediatrics were usually hypo-
tonic. Maintenance requirements for water were tradi-
tionally based on caloric expenditure [53]. This usually 
resulted in glucose-containing solutions with less than 
0.9% NaCl (e.g., 0.67, 0.45 or 0.2% NaCl). Because glu-
cose is metabolized to carbon dioxide and water, the net 
result is a hypotonic solution. This may become problem-
atic if there is a reason for the release of vasopressin. A 
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myriad of non-osmotic stimuli for vasopressin is recog-
nized, including hypovolemia, nausea, pain, the postop-
eratieve state, several drugs or underlying disease (rang-
ing from infections to malignancy) [20]. Indeed, several 
cases of iatrogenic acute hyponatremia due to hypotonic 
IV fluids have been reported in children [54]. In a previ-
ous observational study, we showed that almost half of 
the children with hyponatremia developed this in-hospital 
while receiving more electrolyte-free water in IV fluids 
[55]. In children with gastroenteritis plasma levels of 
vasopressin were frequently high due to vomiting, hypo-
volemia, hypoglycemia, or “stress” [56]. Consequently, 
most children had a urinary tonicity that exceeded that 
of 0.45% saline, predisposing them to the development 
of hyponatremia. In a randomized trial, the same group 
subsequently showed that isotonic IV fluids in children 
with gastroenteritis effectively treat hyponatremia pre-
sent on admission while preventing hospital-acquired 
hyponatremia [57]. More rapid infusion of IV fluids, 
however, did not correct dehydration faster [57]. When 
considering the pediatric patient population as a whole, 
a systematic review (including six studies) confirmed that 
hypotonic solutions greatly increased the risk of devel-
oping hyponatremia [58]. One of the first randomized 
controlled trials that compared 0.45% NaCl with 0.9% 
NaCl in 5% dextrose as maintenance IV-fluids, how-
ever, did not detect an effect on serum sodium, but likely 
lacked power [59]. A larger trial comparing the same 
solutions postoperatively did demonstrate a greater risk 
for hyponatremia with hypotonic fluids [60]. Two meta-
analyses, both including ten randomized controlled trials, 
again confirmed the risk of hyponatremia with hypotonic 
fluids [61, 62]. Despite this increasing body of evidence, 
two additional trials were conducted recently [63, 64]. 
Friedman and colleagues randomized 110 children to 
receive isotonic (0.9% NaCl in 5% dextrose) or hypotonic 
IV fluids (0.45% NaCl in 5% dextrose) at maintenance 
rates for 48 h [63]. The difference in serum sodium con-
centration after 48 h was minimal (1.4 mmol/l), although 
the two children developing hyponatremia were both in 
the hypotonic IV fluid group. The study by McNab et al. 
had a similar set-up, but is of interest for two reasons 
[64]. First, the sample size was large: 690 children who 
required IV fluids for over 6 h. Second, PlasmaLyte was 
used as isotonic IV fluid and was compared with a hypo-
tonic IV fluid containing 77  mmol/l sodium. Patients in 
the isotonic group developed hyponatremia significantly 
less often (11% vs. 4%). Although cerebral edema was 
not more common in the hypotonic group, a trend towards 
more seizures was observed (7 vs. 1 children, p = 0.07). 
In all of these studies isotonic IV fluids did not increase 
the risk of hypernatremia or fluid overload [65]. Overall, 
the message is crystal clear: similar to adults, children 
also require isotonic maintenance IV fluids, and the focus 
should now be on the implementation of this compelling 
evidence [66].
Intravenous fluids to correct electrolyte 
or acid‑base disorders
In addition to replacing fluid loss or maintaining fluid 
balance, IV fluids may also be used specifically to cor-
rect an existing electrolyte or acid-base disorder. IV flu-
ids are instrumental in the treatment of certain subtypes 
of hyponatremia, hypernatremia, metabolic acidosis, and 
metabolic alkalosis, which will be discussed here. IV flu-
ids can also be used as vehicle to correct other electrolyte 
disorders (hypokalemia, hypocalcemia, hypomagnesemia, 
and hypophosphatemia) but this is beyond the scope of this 
review. Because hyponatremia always indicates a positive 
water balance, water restriction or approaches to increase 
renal water excretion are usually the mainstay of treatment. 
However, patients with hyponatremia can be truly hypov-
olemic (e.g., due to vomiting or diarrhea), in which case 
water balance is less negative (relatively positive) in com-
parison to sodium balance. In these patients hyponatremia 
can be corrected by isotonic IV fluids. Because vasopres-
sin release is driven by hypovolemia, a sudden water diu-
resis may occur when the extracellular volume normalizes 
during IV fluid therapy with the risk of (too) rapid correc-
tion of hyponatremia [67]. In addition, acute or sympto-
matic hyponatremia is usually treated by specific IV fluids, 
namely hypertonic saline (usually 3% NaCl). In this context, 
the tonicity rather than the volume of the IV fluid is rel-
evant, as this hypertonic solution will attract water from the 
intracellular compartment. As such, hypertonic saline can 
be used to treat cerebral edema in hyponatremic encepha-
lopathy. The amount of hypertonic saline that should be 
administered can be calculated by the Adrogué–Madias 
formula [68]. More recently, the approach of giving a bolus 
of hypertonic saline has been advocated because it can be 
given rapidly in emergency situations while avoiding cal-
culations [69, 70]. However, a strong evidence base for 
these recommendations is lacking. Ayus et al. did recently 
report their experience with a protocol of uniformly infus-
ing 500 ml 3% hypertonic saline in 6 h in 64 patients with 
hyponatremic encephalopathy [71]. Although this approach 
appeared safe and effective, the patients had severe hypona-
tremia (average serum sodium 114 ± 0.8 mmol/l), in whom 
the distinction between acute or chronic (or acute on 
chronic) hyponatremia is often difficult to make. In addi-
tion, it is important to factor in body weight [72]. In con-
trast to hyponatremia, hypernatremia should be treated 
with hypotonic fluids [73]. If possible, increasing oral 
water intake is preferable, but otherwise half-isotonic or 
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5% dextrose can be used (while avoiding hyperglycemia). 
Of note, patients presenting with hypernatremia can be 
severely hypovolemic and may require initial resuscita-
tion with isotonic saline (that is still relatively hypotonic 
to serum sodium). In patients in whom volume depletion 
is accompanied by metabolic acidosis, sodium bicarbonate 
rather than sodium chloride may be the preferred solution. 
This strategy may be particularly effective in patients who 
lost bicarbonate due to gastrointestinal losses. Intravenous 
sodium bicarbonate is usually reserved for acute metabolic 
acidosis, but it remains controversial when to initiate treat-
ment (usually when pH <7.1). In addition, the focus should 
be on the underlying cause of the acidosis (e.g., ketoacids, 
lactate, or intoxications). If intravenous sodium bicarbonate 
is given, calculating the bicarbonate space helps to assess 
the amount of sodium bicarbonate. Commercially available 
solutions with preset concentrations of sodium bicarbonate 
may be used (e.g., 1.4, 4.2 or 8.4%, Table  3). Depending 
on the concentration of sodium bicarbonate used, hyperna-
tremia is a potential side-effect [74]. An alternative solu-
tion in this regard is tris-hydroxymethylaminomethase 
(THAM), an amino alcohol which buffers acids and carbon 
dioxide [75]. In patients with lactic acidosis due to sepsis 
or a low-flow state, sodium bicarbonate does not improve 
outcomes [76, 77]. Experimentally, the negative effects of 
sodium bicarbonate (lowering of serum calcium and gener-
ation of carbon dioxide) can be effectively targeted by cal-
cium supplementation and hyperventilation, but clinical tri-
als are lacking [76, 78]. The much-criticized high chloride 
concentration of normal saline may actually benefit patients 
with so-called chloride depletion metabolic alkalosis [79, 
80]. This usually concerns patients who lost large amounts 
of hydrogen chloride from their upper gastrointestinal tract. 
In these patients hypochloremia is central to the pathogen-
esis of metabolic alkalosis, as it will directly impair renal 
bicarbonate excretion. Thus, whatever the place of the 
newer balanced crystalloid solution may become, normal 
saline will still remain the treatment of choice for chloride 
depletion metabolic alkalosis.
Conclusions
Electrolyte solutions are part of our daily clinical practice. 
The use of isotonic rather than hypotonic maintenance 
IV fluids is now well established, especially in pediatrics 
(Table 4) [64]. The comparison between normal saline and 
balanced crystalloid solutions, however, is still undecided. 
Although balanced crystalloid IV fluids have physiological 
appeal given their resemblance to human plasma (Table 3), 
strong evidence in favor of their general use is still lack-
ing  (Table  4). Normal saline can cause hyperchloremic 
acidosis, which, in turn, may negatively affect renal blood 
flow [42, 43]. Although preliminary studies indeed showed 
a higher degree of AKI and RRT in patients treated with 
normal saline compared to balanced crystalloids [46, 47], 
a recent large randomized controlled trial failed to confirm 
these differences [48]. Such differences in outcome may be 
especially evident in patients receiving large volumes of IV 
fluids, providing a potential focus for future trials. Simi-
larly, in the setting of kidney transplantation, prevention of 
hyperchloremic acidosis may be most relevant in patients 
receiving a cadaveric donor, in whom delayed graft func-
tion is a common problem. Regardless of these interest-
ing developments in the field of IV fluids, the first critical 
assessment should be whether the patient actually requires 
IV fluids, and if so, to tailor this to the specific characteris-
tics of that individual patient.
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